Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
Saved in:
| Main Author: | Editorial team Diabetes Mellitus |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2009-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5405 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
by: Alexander Sergeevich Ametov, et al.
Published: (2010-06-01) -
Vildagliptin and its role in the treatment of diabetes mellitus
by: Yury Shavkatovich Khalimov
Published: (2010-09-01) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2012-06-01) -
The MET Oncogene: An Update on Targeting Strategies
by: Simona Gallo, et al.
Published: (2024-11-01) -
Series of International Russian-American educational conferences on diabetes. Advances in Diabetes: from research to clinical practice?
by: Editorial team Diabetes Mellitus
Published: (2012-12-01)